Venous Thromboembolism with Contemporary Lenalidomide-Based Regimens and Adequate Thromboprophylaxis in Newly Diagnosed Multiple Myeloma: A Systemic Review and Meta-Analysis

被引：0
|
作者：
Chakraborty, Rajshekhar [1 ]
Malik, Saad Ullah [2 ]
Marneni, Naimisha [3 ]
Garcia, Alex V. Mejia [3 ]
Anwer, Faiz [1 ,4 ]
Khorana, Alok A. [5 ]
Majhail, Navneet S. [6 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Univ Arizona, Tucson, AZ USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Univ Arizona, Tucson, AZ USA
[5] Cleveland Clin Fdn, Taussig Canc Ctr, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
[6] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4835
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Venous Thromboembolism Risk in Patients with Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination with Lenalidomide and Dexamethasone
    Loncharich, Alexa J.
    Fiala, Mark A.
    Slade, Michael J.
    Vickroy, Angela
    Kavanaugh, Margaret
    Wilson, Kari
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    Sanfilippo, Kristen M.
    BLOOD, 2022, 140 : 8550 - 8551
  • [22] (Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
    Wang, Anyou
    Duan, Qiaohong
    Liu, Xin
    Ding, Kaiyang
    Han, Yongsheng
    Zhu, Weibo
    Cai, Xiaoyan
    Wu, Jingsheng
    Sun, Zimin
    ANNALS OF HEMATOLOGY, 2012, 91 (11) : 1779 - 1784
  • [23] (Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
    Anyou Wang
    Qiaohong Duan
    Xin Liu
    Kaiyang Ding
    Yongsheng Han
    Weibo Zhu
    Xiaoyan Cai
    Jingsheng Wu
    Zimin Sun
    Annals of Hematology, 2012, 91 : 1779 - 1784
  • [24] Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis
    Costa, Bruno Almeida
    Costa, Thomaz Alexandre
    Saravia, Sara Diaz
    Felix, Nicole
    Tan, Carlyn Rose
    Korde, Neha
    Richter, Joshua
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (06) : 1056 - 1065
  • [25] Efficacy and safety analysis of bortezomib-based triplet regimens sequential lenalidomide in newly diagnosed multiple myeloma patients
    Zhou, Qiaolin
    Xu, Fang
    Wen, Jingjing
    Yue, Jing
    Zhang, Ya
    Su, Jing
    Liu, Yiping
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1573 - 1580
  • [26] Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta-analysis
    Mohyuddin, Ghulam Rehman
    Aziz, Muhammad
    McClune, Brian
    Abdallah, Al-Ola
    Qazilbash, Muzaffar
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (05) : 420 - 426
  • [27] Efficacy and safety analysis of bortezomib-based triplet regimens sequential lenalidomide in newly diagnosed multiple myeloma patients
    Qiaolin Zhou
    Fang Xu
    Jingjing Wen
    Jing Yue
    Ya Zhang
    Jing Su
    Yiping Liu
    Clinical and Experimental Medicine, 2023, 23 : 1573 - 1580
  • [28] Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis
    Facon, Thierry
    San-Miguel, Jesus
    Dimopoulos, Meletios A.
    Mateos, Maria-Victoria
    Cavo, Michele
    van Beekhuizen, Sophie
    Yuan, Zijiao
    Mendes, Joao
    Lam, Annette
    He, Jianming
    Ammann, Eric
    Kumar, Shaji
    ADVANCES IN THERAPY, 2022, 39 (05) : 1976 - 1992
  • [29] Carfilzomib Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review
    Khan, Maimoona
    Waheed, Asma
    Ul Jannat, Rida
    Farooqui, Arafat Ali Ali
    Farooqi, Muhammad Saad
    Khan, Ali Younas
    Shafqat, Madeeha
    Ahmad, Muhaddis Ejaz
    Yousaf, Muhammad Abdullah
    Syed, Tariq Iqtidar Sadiq
    Abdullah, Syed Maaz
    Kotapati, Sravanthi
    Riaz, Irbaz
    Anwer, Faiz
    BLOOD, 2019, 134
  • [30] Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis
    Wang, Jiasheng
    Kim, Yeseong
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (05) : 650 - 657
12345